Immuneering Corp. (IMRX)
6.24
-0.28
(-4.29%)
USD |
NASDAQ |
Dec 09, 16:00
6.35
+0.11
(+1.76%)
After-Hours: 20:00
Immuneering Shareholders Equity (Quarterly): 227.98M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Fortress Biotech, Inc. | 55.86M |
| BridgeBio Pharma, Inc. | -1.933B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 241.06M |
| Total Liabilities (Quarterly) | 13.08M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 24.00 |
| Net Debt Paydown Yield | 0.02% |